James A Cranford1, J Todd Arnedt2, Deirdre A Conroy2, Kipling M Bohnert3, Carrie Bourque2, Frederic C Blow3, Mark Ilgen3. 1. Department of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109-2700, United States. Electronic address: jcranfor@med.umich.edu. 2. Department of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109-2700, United States. 3. Department of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109-2700, United States; VA Center for Clinical Management Research (CCMR), Veterans Health Administration, 2215 Fuller Road, Mail Stop 152, Ann Arbor, MI, 48105, United States.
Abstract
PURPOSE: To examine the prevalence and correlates of sleep problems in a sample of medical cannabis patients. PROCEDURES: Adults ages 21 and older (N=801,M age=45.8) who were seeking medical cannabis certification (either for the first time or as a renewal) for chronic pain at medical cannabis clinics in southern Michigan completed baseline measures of cannabis use, sleep, pain, and other related constructs. FINDINGS: Over half of the sample (59%) met criteria for past 1-month sleep disturbance, defined as at least one sleep problem occurring on 15 or more nights in the past month. Most participants (86%) reported that sleep problems were due to their current pain. Approximately 80% of participants reported using cannabis in the past 6 months to improve sleep and, among these participants, cannabis was rated as helpful for improving sleep. Sleep-related cannabis side effects were rare (35%), but sleep-related cannabis withdrawal symptoms were relatively common (65%). Statistically significant correlates of past 1-month sleep disturbance included a) being female, b) being white, c) being on disability, d) not having a medical cannabis card, and e) frequency of using cannabis to help sleep. CONCLUSIONS: Sleep problems are highly prevalent and frequent in medical cannabis patients and are closely tied to pain. Sleep-related cannabis withdrawal symptoms are relatively common but their clinical relevance is unknown. The association between frequency of cannabis use to help sleep with higher odds of sleep problems will need to be clarified by longitudinal studies.
PURPOSE: To examine the prevalence and correlates of sleep problems in a sample of medical cannabis patients. PROCEDURES: Adults ages 21 and older (N=801,M age=45.8) who were seeking medical cannabis certification (either for the first time or as a renewal) for chronic pain at medical cannabis clinics in southern Michigan completed baseline measures of cannabis use, sleep, pain, and other related constructs. FINDINGS: Over half of the sample (59%) met criteria for past 1-month sleep disturbance, defined as at least one sleep problem occurring on 15 or more nights in the past month. Most participants (86%) reported that sleep problems were due to their current pain. Approximately 80% of participants reported using cannabis in the past 6 months to improve sleep and, among these participants, cannabis was rated as helpful for improving sleep. Sleep-related cannabis side effects were rare (35%), but sleep-related cannabis withdrawal symptoms were relatively common (65%). Statistically significant correlates of past 1-month sleep disturbance included a) being female, b) being white, c) being on disability, d) not having a medical cannabis card, and e) frequency of using cannabis to help sleep. CONCLUSIONS: Sleep problems are highly prevalent and frequent in medical cannabis patients and are closely tied to pain. Sleep-related cannabis withdrawal symptoms are relatively common but their clinical relevance is unknown. The association between frequency of cannabis use to help sleep with higher odds of sleep problems will need to be clarified by longitudinal studies.
Authors: Thomas Roth; Catherine Coulouvrat; Goeran Hajak; Matthew D Lakoma; Nancy A Sampson; Victoria Shahly; Alicia C Shillington; Judith J Stephenson; James K Walsh; Ronald C Kessler Journal: Biol Psychiatry Date: 2010-12-31 Impact factor: 13.382
Authors: James A Cranford; Kipling M Bohnert; Brian E Perron; Carrie Bourque; Mark Ilgen Journal: Drug Alcohol Depend Date: 2016-10-15 Impact factor: 4.492
Authors: Margaret Park; Aron S Buchman; Andrew S P Lim; Sue E Leurgans; David A Bennett Journal: Am J Geriatr Psychiatry Date: 2013-03-25 Impact factor: 4.105
Authors: Erin E Bonar; James A Cranford; Brooke J Arterberry; Maureen A Walton; Kipling M Bohnert; Mark A Ilgen Journal: Drug Alcohol Depend Date: 2019-01-09 Impact factor: 4.492
Authors: Danielle C Hergert; Cidney Robertson-Benta; Veronik Sicard; Daniela Schwotzer; Kent Hutchison; Dan P Covey; Davin K Quinn; Joseph R Sadek; Jacob McDonald; Andrew R Mayer Journal: J Neurotrauma Date: 2021-01-25 Impact factor: 4.869
Authors: Dena Zeraatkar; Matthew Adam Cooper; Arnav Agarwal; Robin W M Vernooij; Gareth Leung; Kevin Loniewski; Jared E Dookie; Muhammad Muneeb Ahmed; Brian Y Hong; Chris Hong; Patrick Hong; Rachel Couban; Thomas Agoritsas; Jason W Busse Journal: BMJ Open Date: 2022-08-04 Impact factor: 3.006
Authors: Mary Beth Miller; Ashley F Curtis; Wai Sze Chan; Chelsea B Deroche; Christina S McCrae Journal: J Clin Sleep Med Date: 2021-04-01 Impact factor: 4.324
Authors: Nicolas J Schlienz; Ryan Scalsky; Erin L Martin; Heather Jackson; Joel Munson; Justin C Strickland; Marcel O Bonn-Miller; Mallory Loflin; Ryan Vandrey Journal: Cannabis Cannabinoid Res Date: 2020-06-08